Publications by authors named "S Tezcan"

Article Synopsis
  • Batten, a species previously known from Cyprus and Greece, has been reported in Italy and Turkey for the first time.
  • The species was redescribed using type specimens and new materials from its entire known range, and DNA barcoding sequences were analyzed from samples in Greece, Cyprus, and Italy.
  • Three mitochondrial haplotypes were identified: one shared between Italian mainland specimens and those from Rhodes and Cyprus, a distinct haplotype from Sardinia, and another from a single specimen in Cyprus.
View Article and Find Full Text PDF

Background: Oral inhaler medications (OIMs) are widely used for many respiratory diseases. Although OIMs have minimal systemic effects, they may cause potential drug-drug interactions (pDDIs).Objectives: This study aims to evaluate drug interactions in patients using OIMs.

View Article and Find Full Text PDF

Drug stability and compatibility are critical factors influencing the cost and logistics of treatment delivery, therapeutic effectiveness, and patient safety. This is particularly significant in the realm of cancer chemotherapeutics, where stability and compatibility studies play a vital role in ensuring rational and safe medicine administration. Oxaliplatin, fluorouracil, and irinotecan, commonly used in various combinations for gastrointestinal cancers, are complemented by co-administration of folinic acid in certain protocols.

View Article and Find Full Text PDF

Background: Type 2 time-intensity curves can indicate both malignant and benign breast lesions in dynamic contrast enhanced magnetic resonance imaging (DCE-MRI).

Purpose: To investigate whether diffusion-weighted imaging (DWI) or early phase kinetics of DCE-MRI is practical to discriminate breast masses that depict type 2 curve in DCE-MRI.

Material And Methods: We retrospectively included 107 lesions in 97 patients with type 2 curves in DCE-MRI.

View Article and Find Full Text PDF

Objective: The aim of this study was to evaluate the diagnostic performance of multiparametric magnetic resonance imaging for clinically significant prostate cancer and to determine whether applying Prostate Imaging Reporting and Data Systems version 2.1 score could improve the diagnostic pathway besides the biochemical characteristics.

Materials And Methods: In this study, 199 patients with clinically suspected prostate cancer who underwent multiparametric magnetic resonance imaging were included.

View Article and Find Full Text PDF